Lifecore Biomedical Inc
NASDAQ:LFCR
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
3.815
8.55
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Lifecore Biomedical Inc
Gross Margin
Lifecore Biomedical Inc
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Gross Margin Across Competitors
| Country | US |
| Market Cap | 269.2m USD |
| Gross Margin |
35%
|
| Country | JP |
| Market Cap | 53.2T JPY |
| Gross Margin |
34%
|
| Country | CH |
| Market Cap | 195.4B CHF |
| Gross Margin |
47%
|
| Country | US |
| Market Cap | 86.1B USD |
| Gross Margin |
39%
|
| Country | FR |
| Market Cap | 42.1B EUR |
| Gross Margin |
48%
|
| Country | ZA |
| Market Cap | 39B Zac |
| Gross Margin |
28%
|
| Country | US |
| Market Cap | 38.5B USD |
| Gross Margin |
35%
|
| Country | ZA |
| Market Cap | 36.4B Zac |
| Gross Margin |
42%
|
| Country | US |
| Market Cap | 36.1B USD |
| Gross Margin |
35%
|
| Country | US |
| Market Cap | 35.4B USD |
| Gross Margin |
44%
|
| Country | CN |
| Market Cap | 241.4B CNY |
| Gross Margin |
35%
|
Lifecore Biomedical Inc
Glance View
Lifecore Biomedical, Inc. engages in the design, development, manufacture, and sale of health and wellness products for food and biomaterials markets. The company is headquartered in Chaska, Minnesota and currently employs 689 full-time employees. The firm offers highly differentiated capabilities in the development, fill and finish of complex sterile injectable pharmaceutical products in syringes and vials, as well as the manufacture of pharmaceutical-grade Hyaluronic Acid. The company provides complete CDMO services for injectable pharmaceuticals and medical devices. The Company’s services include sodium hyaluronate, development, manufacturing, and analytical services. The company offers a range of average molecular weights and custom modifications for research and development (R&D), clinical, and commercial applications. The Company’s therapeutic applications include drug delivery, biomaterials, ophthalmology, orthopedics, aesthetics, oncology, and pain management. Its development capabilities include formulation, sterile filtration, filling, packaging, testing, and secondary sterilization.
See Also
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Based on Lifecore Biomedical Inc's most recent financial statements, the company has Gross Margin of 34.7%.
You don't have any saved screeners yet
